• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病中的唾液酸

Sialic acid in sickle cell disease.

作者信息

Ekeke G I, Ibeh G O

机构信息

Department of Biochemistry, University of Port Harcourt, Nigeria.

出版信息

Clin Chem. 1988 Jul;34(7):1443-6.

PMID:3390914
Abstract

Neuraminic (sialic) acid concentrations in serum from normal and sickle cell (HbSS) subjects were determined for discrete age groups from childhood through adolescence. Values in sickle cell disease were consistently lower over the entire age range. We further investigated the effect of exogenous sialic acid on the rate of sickling reversion of HbSS erythrocytes and demonstrated that this compound in millimole per liter concentrations could revert pre-sickled erythrocytes to their normal morphology in a concentration-dependent manner. When subjected to partial de-sialation with sialidase (EC 3.2.1.18), the HbSS erythrocytes not only sickled faster upon deoxygenation, they also reverted more slowly on treatment with phenylalanine (a more efficient anti-sickling agent than sialic acid) than did untreated cells. We conclude that, in sickle cell disease, erythrocyte sialic acid content could play a significant role, not only in the control of the sickling rate in vivo, but also, after sickling has occurred, in the rate of recovery from a sickling crisis.

摘要

测定了从儿童期到青春期各离散年龄组正常人和镰状细胞病(HbSS)患者血清中的神经氨酸(唾液酸)浓度。在整个年龄范围内,镰状细胞病患者的值始终较低。我们进一步研究了外源性唾液酸对HbSS红细胞镰变逆转率的影响,结果表明,以毫摩尔每升浓度计的该化合物可使预镰变红细胞以浓度依赖的方式恢复其正常形态。当用唾液酸酶(EC 3.2.1.18)进行部分去唾液酸化处理时,HbSS红细胞不仅在脱氧时镰变更快,而且在用苯丙氨酸(一种比唾液酸更有效的抗镰变剂)处理后,其恢复正常形态的速度也比未处理的细胞慢。我们得出结论,在镰状细胞病中,红细胞唾液酸含量不仅在体内镰变率的控制中可能起重要作用,而且在镰变发生后,在镰变危机恢复的速率中也可能起重要作用。

相似文献

1
Sialic acid in sickle cell disease.镰状细胞病中的唾液酸
Clin Chem. 1988 Jul;34(7):1443-6.
2
Erythrocyte sialic acid in human sickle-cell disease.人类镰状细胞病中的红细胞唾液酸
J Comp Pathol. 1987 Mar;97(2):143-7. doi: 10.1016/0021-9975(87)90034-x.
3
Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.镰状细胞贫血患者红细胞中的膜成分。与细胞衰老及镰变不可逆性的关系。
Biochim Biophys Acta. 1979 Oct 19;557(1):149-55. doi: 10.1016/0005-2736(79)90097-x.
4
Sialic acid content of erythrocytes in normal individuals and patients with certain hematologic disorders.正常个体及某些血液系统疾病患者红细胞中的唾液酸含量
Am J Hematol. 1980;9(4):381-9. doi: 10.1002/ajh.2830090405.
5
Perfluorocarbon compounds: effects on the rheological properties of sickle erythrocytes in vitro.全氟碳化合物:对镰状红细胞体外流变学特性的影响
Am J Hematol. 1985 Jul;19(3):229-36. doi: 10.1002/ajh.2830190304.
6
The antisickling role of uric acid in sickle cell disease.尿酸在镰状细胞病中的抗镰变作用。
Trop Geogr Med. 1987 Apr;39(2):152-6.
7
Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation.在逐步脱氧过程中,BW12C对镰状细胞可变形性(过滤性)的保存作用。
Br J Haematol. 1983 Nov;55(3):465-71. doi: 10.1111/j.1365-2141.1983.tb02161.x.
8
Sickling-induced binding of immunoglobulin to sickle erythrocytes.镰变诱导免疫球蛋白与镰状红细胞的结合。
Blood. 1988 Mar;71(3):636-9.
9
Anti-sickling activities of two isolated compounds from the root of Combretum racemosum P. beauv. (Combretaceae).从使君子科(Combretaceae)的团花根中分离得到的两种化合物的抗镰状化活性。
J Ethnopharmacol. 2021 Jun 12;273:113992. doi: 10.1016/j.jep.2021.113992. Epub 2021 Mar 4.
10
Interaction of phosphatidylserine-phosphatidylcholine liposomes with sickle erythrocytes. Evidence for altered membrane surface properties.磷脂酰丝氨酸 - 磷脂酰胆碱脂质体与镰状红细胞的相互作用。膜表面性质改变的证据。
J Clin Invest. 1983 Jun;71(6):1570-80. doi: 10.1172/jci110913.

引用本文的文献

1
Aberrant GPA expression and regulatory function of red blood cells in sickle cell disease.镰状细胞病中红细胞 GPA 表达异常及调控功能。
Blood Adv. 2024 Apr 9;8(7):1687-1697. doi: 10.1182/bloodadvances.2023011611.
2
Characterization and statistical modeling of glycosylation changes in sickle cell disease.镰状细胞病中糖基化变化的特征描述和统计建模。
Blood Adv. 2021 Mar 9;5(5):1463-1473. doi: 10.1182/bloodadvances.2020003376.
3
Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease.
Siglec-9 与红细胞结合减少可增加镰状细胞病中性粒细胞的激活。
Blood Cells Mol Dis. 2020 Mar;81:102399. doi: 10.1016/j.bcmd.2019.102399. Epub 2019 Dec 20.